ArticleFrontiers in cell and developmental biology2021

BRCC3 Promotes Tumorigenesis of Bladder Cancer by Activating the NF-κB Signaling Pathway Through Targeting TRAF2.

Huangheng Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.